Omrix Biopharmaceuticals, Inc.
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001349426
0001349426
EIN:
52-2147005
52-2147005
LEI:
(CF Office: )
Business address:
630 FIFTH AVENUE, 22ND FLOOR, NEW YORK, NY, 10111
Phone: (212) 887-6500
630 FIFTH AVENUE, 22ND FLOOR, NEW YORK, NY, 10111
Phone: (212) 887-6500
Mailing address:
630 FIFTH AVENUE, 22ND FLOOR, NEW YORK, NY, 10111
630 FIFTH AVENUE, 22ND FLOOR, NEW YORK, NY, 10111
Category:
Filings:
206 EDGAR filings since January 18, 2006
206 EDGAR filings since January 18, 2006
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- February 17, 2009 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2009 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 30, 2008 - 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Open documentClick to Open document FilingOpen filingClick to Open filing
- December 30, 2008 - 15F-12G: Securities registration termination of foreign private issuers [Section 12(g)] Open documentClick to Open document FilingOpen filingClick to Open filing
- December 30, 2008 - SC 13D/A: General statement of acquisition of beneficial ownership - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
No 8-K filing data for this company in last 110 days
[+] 10-K (annual reports) and 10-Q (quarterly reports)
No 10-K/10-Q filings for this company in last 365
days
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
No insider transaction filings for this company in last 365 days
- Beneficial ownership (Schedule 13D and 13G)
No beneficial ownership filings for this company in last 365 days
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 206 entries
Data source:
CIK0001349426.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
